IMGT(R), the international ImMunoGeneTics information system(R)

Marie‐Paule Lefranc(Institut de Génétique Moléculaire de Montpellier), Véronique Giudicelli(Laboratoire d'Informatique Gaspard-Monge), Chantal Ginestoux(Centre National de la Recherche Scientifique), Joumana Jabado-Michaloud(Université de Montpellier), Gerard Folch(Centre National de la Recherche Scientifique), Fatena Bellahcene(Centre National de la Recherche Scientifique), Y. Wu(Université de Montpellier), Elodie Gemrot(Centre National de la Recherche Scientifique), Xavier Brochet(Laboratoire d'Informatique Gaspard-Monge), Jerome C. Lane(Laboratoire d'Informatique Gaspard-Monge), Laetitia Regnier(Université de Montpellier), François Ehrenmann(Institut de Génétique Humaine), Marie‐Paule Lefranc(Laboratoire d'Informatique Gaspard-Monge), Patrice Duroux(Université de Montpellier)
Nucleic Acids Research
October 31, 2008
Cited by 1,144Open Access
Full Text

Abstract

IMGT, the international ImMunoGeneTics information system (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc, Laboratoire d'ImmunoGénétique Moléculaire LIGM (Université Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and manage the complexity of immunogenetics data. The building of a unique ontology, IMGT-ONTOLOGY, has made IMGT the global reference in immunogenetics and immunoinformatics. IMGT is a high-quality integrated knowledge resource specialized in the immunoglobulins or antibodies, T cell receptors, major histocompatibility complex, of human and other vertebrate species, proteins of the IgSF and MhcSF, and related proteins of the immune systems of any species. IMGT provides a common access to standardized data from genome, proteome, genetics and 3D structures. IMGT consists of five databases (IMGT/LIGM-DB, IMGT/GENE-DB, IMGT/3Dstructure-DB, etc.), fifteen interactive online tools for sequence, genome and 3D structure analysis, and more than 10,000 HTML pages of synthesis and knowledge. IMGT is used in medical research (autoimmune diseases, infectious diseases, AIDS, leukemias, lymphomas and myelomas), veterinary research, biotechnology related to antibody engineering (phage displays, combinatorial libraries, chimeric, humanized and human antibodies), diagnostics (clonalities, detection and follow-up of residual diseases) and therapeutical approaches (graft, immunotherapy, vaccinology). IMGT is freely available at http://www.imgt.org.


Related Papers